鹦鹉螺体育 NLS 深 沪
等待开盘 08-14 09:30:00 美东时间
0.8204
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.8204
- 总市值 2960.82万
- 52周最高 2.17
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.641
- 委 比 0.00%
- 总股本 3609.00万
- 历史最高 31.38
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.641
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FiscalNote Holdings Amends Convertible Promissory Notes
FiscalNote Holdings ( ($NOTE) ) just unveiled an update. On July 30, 2025, Fisc...
08-06 05:20
西安市未央区市场监督管理局通告（2025年第22号）
近期，西安市未央区市场监督管理局组织抽检餐饮食品，淀粉及淀粉制品，调味品，豆制品，方便食品，罐头，酒类，可可及焙烤咖啡产品，冷冻饮品，粮食加工品，肉制品，乳制品...
08-05 11:22
Nautilus Biotechnology’s Q2 2025 Financial Highlights
Nautilus Biotechnolgy, Inc. ( ($NAUT) ) has released its Q2 earnings. Here is a...
08-01 13:25
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Proteomics Market to Expand Rapidly, With 13% CAGR Forecast Through 2030
"Advances in proteomics technologies are driving growth in precision medicine, ...
07-26 00:13
NLS Pharma's Diabetes Treatment Project Gets Fresh Funding Boost From US-Israel Foundation
NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system disorders, today announced that the Israel-U.S. Binational Industrial Research and
07-17 19:02
NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing
Accumulated proceeds of $3 million including the initial closing held in March 2025 ZÜRICH, June 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) ("NLS" or the "Company"), a Sw...
06-30 19:00
Nautilus Biotechnology Announces Board Restructuring
An update from Nautilus Biotechnolgy ( ($NAUT) ) is now available. Nautilus Bio...
06-24 05:01
福特因后视摄像头故障召回110万辆汽车
美国国家公路交通安全管理局（NHTSA）周一公告显示，福特汽车正在全美召回1075299辆汽车，原因是后视摄像头显示可能因软件故障卡顿。 该问题...
06-02 22:45
Nautilus Biotechnology targets late 2026 platform launch amid proteoform assay advancements
Earnings Call Insights: Nautilus Biotechnology (NAUT) Q1 2025 Management View CEO Sujal Patel highlighted progress in advancing Nautilus' proteome analysis platform, focusing on targeted proteoform de...
04-30 01:01
